1st Dutch Antisense Therapeutics Symposium
December 3rd 2021, Leiden
9:30 - Arrival, Registration and Coffee
9:55 - Welcome
10:00 National keynote lecture
Annemieke Aartsma-Rus (LUMC): A brief history of exon-skipping therapy development: Developments in the current millennium.
SESSION 1
10:45 Rick Wansink (Radboudumc) - Peptide-based delivery strategies for antisense oligonucleotides
11:15 Peter van den Akker (UMCG) - Exon-skipping therapy for dystrophic epidermolysis bullosa
11:45 Saskia A.J. Lesnik Oberstein (LUMC) - Skipping NOTCH3 exons to prevent protein aggregation in CADASIL patient arteries
11:45 Ype Elgersma (ErasmusMC) - Dutch Center for RNA Therapeutics
12:30 Lunch
SESSION 2
13:15 Early Career Investigator Presentations*
13:15 To be announced after abstract selection
13:30 To be announced after abstract selection
13:45 To be announced after abstract selection
14:00 To be announced after abstract selection
14:15 International Keynote Lecture:
Bruno Godinho (Atlanta Therapeutics) - Delivery of stabilized siRNA scaffolds to the central nervous system
15:00 Marjon Pasmooij (Medicines Evaluation Board) - Antisense to medicine: a regulator’s perspective
15:30 Poster Pitches*
15:45 POSTER SESSION with Coffee and Cookies
SESSION 3
17:00 Mike Schwartz (ProQR Therapeutics) - Results of first-in-human clinical data of intravitreal sepofarsen (QR-110) antisense oligonucleotide in Leber congenital amaurosis type 10
17:30 Elizabeth Vroom (Duchenne Parent Project Netherlands) - The role of patient organizations in antisense oligonucleotide drug development
18:00 Awards, closing remarks
18:10 Drinks and Networking
19:30 Dinner (not included, pre-registration required)
*Deadline for abstract submission: November 17th 2021
*Announcement of the selected abstracts for presentation and poster pitches: November 19th 2021
Abstract book will be available digitally two weeks before the meeting.
For more info click here
EVENT SPONSORED BY:
